Genome-wide analysis toward the epigenetic aetiology of myelodysplastic syndrome disease progression and pharmacoepigenomic basis of hypomethylating agents drug treatment response.
Hum Genomics
; 17(1): 37, 2023 04 25.
Article
in En
| MEDLINE
| ID: mdl-37098643
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Myelodysplastic Syndromes
/
DNA Methylation
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Year:
2023
Type:
Article